Vericel Corp SEC filings VCEL

Vericel Corp has 1,002 filings in SEC EDGAR's recent list, going back to Aug 7, 2013. Its latest annual report, Form ARS, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Vericel Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
8-K Current report
Bylaw or fiscal year change
May 18, 2026 May 18, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Shareholder vote results
May 1, 2026 Apr 29, 2026
DEFA14A Additional proxy material Mar 19, 2026 —
DEF 14A Proxy statement Mar 19, 2026 Apr 29, 2026
ARS Annual report to shareholders Mar 19, 2026 Dec 31, 2025
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2026 Jan 13, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
S-8 Employee stock plan registration May 8, 2025 —
S-8 Employee stock plan registration May 8, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 2, 2025 Apr 30, 2025
8-K Current report
Regulation FD disclosure
Apr 14, 2025 Apr 14, 2025
DEFA14A Additional proxy material Mar 20, 2025 —
DEF 14A Proxy statement Mar 20, 2025 Apr 30, 2025
ARS Annual report to shareholders Mar 20, 2025 Dec 31, 2024
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Aug 26, 2024 Aug 26, 2024
S-3ASR Automatic shelf registration Aug 16, 2024 —
8-K Current report
Other events
Aug 15, 2024 Aug 15, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
8-K Current report
Shareholder vote results
May 3, 2024 May 1, 2024
ARS Annual report to shareholders Mar 21, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 21, 2024 —
DEF 14A Proxy statement Mar 21, 2024 May 1, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Other events
Sep 20, 2023 Sep 20, 2023
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
S-8 Employee stock plan registration May 22, 2023 —
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 10, 2023 May 10, 2023
8-K Current report
Officer or director change, Shareholder vote results
May 5, 2023 May 3, 2023
ARS Annual report to shareholders Mar 23, 2023 Dec 31, 2022
DEFA14A Additional proxy material Mar 23, 2023 —
DEF 14A Proxy statement Mar 23, 2023 —
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2023 Jan 10, 2023
8-K Current report
Other events
Dec 29, 2022 Dec 29, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Material agreement, New debt
Aug 2, 2022 Jul 29, 2022
S-8 POS Filing May 6, 2022 —
S-8 POS Filing May 6, 2022 —
S-8 Employee stock plan registration May 6, 2022 —
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
8-K Current report
Officer or director change, Shareholder vote results
Apr 29, 2022 Apr 27, 2022
DEFA14A Additional proxy material Mar 17, 2022 —
DEF 14A Proxy statement Mar 17, 2022 Apr 27, 2022
8-K Current report
Officer or director change
Feb 24, 2022 Feb 16, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Material agreement, New debt
Feb 2, 2022 Jan 28, 2022
CT ORDER Filing Jan 19, 2022 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2022 Jan 12, 2022
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Material agreement
Aug 27, 2021 Aug 27, 2021
S-3ASR Automatic shelf registration Aug 27, 2021 —
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
8-K Current report
Other events
Jun 29, 2021 Jun 29, 2021
8-K Current report
Officer or director change
Jun 21, 2021 Jun 15, 2021
8-K Current report
Officer or director change
Jun 2, 2021 Jun 1, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
8-K Current report
Shareholder vote results
Apr 29, 2021 Apr 28, 2021
DEFA14A Additional proxy material Mar 19, 2021 —
DEF 14A Proxy statement Mar 19, 2021 Apr 28, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-A12B/A Filing Feb 12, 2021 —
8-K Current report
Material agreement, Agreement ended, Change to shareholder rights, Other events
Feb 12, 2021 Feb 11, 2021
8-K Current report
Officer or director change
Jan 25, 2021 Jan 25, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Oct 14, 2020 Oct 14, 2020
8-K Current report
Other events
Sep 16, 2020 Sep 16, 2020
8-K Current report
Officer or director change
Sep 8, 2020 Sep 1, 2020
S-8 Employee stock plan registration Aug 6, 2020 —
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Jul 9, 2020 Jul 9, 2020
8-K Current report
Other events
Jun 30, 2020 Jun 30, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 5, 2020 May 5, 2020
8-K Current report
Officer or director change, Shareholder vote results
May 1, 2020 Apr 29, 2020
DEFA14A Additional proxy material Apr 10, 2020 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Apr 2, 2020 Apr 2, 2020
DEF 14A Proxy statement Mar 20, 2020 Apr 29, 2020
10-K Annual report Feb 25, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 25, 2020 Feb 25, 2020
SEC STAFF LETTER Filing Nov 19, 2019 —
UPLOAD Letter from the SEC Nov 19, 2019 —
CORRESP Letter to the SEC Nov 13, 2019 —
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
UPLOAD Letter from the SEC Nov 5, 2019 —
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
SEC STAFF LETTER Filing Nov 4, 2019 —
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
8-K Current report
Officer or director change
Jun 3, 2019 May 28, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
8-K Current report
Material agreement
May 7, 2019 May 6, 2019
8-K Current report
Regulation FD disclosure
May 7, 2019 May 7, 2019
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 Employee stock plan registration May 1, 2019 —
8-K Current report
Officer or director change, Shareholder vote results
May 1, 2019 May 1, 2019
DEF 14A Proxy statement Mar 20, 2019 May 1, 2019
10-K Annual report Feb 26, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 26, 2019 Feb 26, 2019
8-K Current report
Agreement ended
Dec 20, 2018 Dec 14, 2018
CT ORDER Filing Nov 28, 2018 —
10-Q Quarterly report Nov 6, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 6, 2018 Nov 6, 2018
EFFECT Filing Aug 28, 2018 —
UPLOAD Letter from the SEC Aug 28, 2018 —
CORRESP Letter to the SEC Aug 24, 2018 —
S-3 Shelf registration Aug 16, 2018 —
10-Q Quarterly report Aug 6, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 6, 2018 Aug 6, 2018
8-K Current report
Material agreement
Jul 31, 2018 Jul 25, 2018
CT ORDER Filing Jun 6, 2018 —
8-K Current report
Material agreement
Jun 1, 2018 May 31, 2018
424B5 Prospectus supplement Jun 1, 2018 —
S-3MEF Filing May 31, 2018 —
424B5 Prospectus supplement May 30, 2018 —
8-K Current report
Agreement ended
May 30, 2018 May 29, 2018
10-Q Quarterly report May 8, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 8, 2018 May 8, 2018
8-K Current report
Shareholder vote results
May 3, 2018 May 2, 2018
CT ORDER Filing Apr 6, 2018 —
DEF 14A Proxy statement Mar 22, 2018 May 2, 2018
10-K Annual report Mar 5, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 5, 2018 Mar 5, 2018
CT ORDER Filing Jan 11, 2018 —
8-K Current report
Regulation FD disclosure
Jan 8, 2018 Jan 8, 2018
8-K Current report
Material agreement, Unregistered share sale
Dec 28, 2017 Dec 21, 2017
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Dec 8, 2017 Dec 6, 2017
UPLOAD Letter from the SEC Nov 15, 2017 —
CT ORDER Filing Nov 14, 2017 —
10-Q Quarterly report Nov 7, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 7, 2017 Nov 7, 2017
CORRESP Letter to the SEC Oct 18, 2017 —
UPLOAD Letter from the SEC Oct 5, 2017 —
8-K Current report
Material agreement, Officer or director change
Sep 19, 2017 Sep 14, 2017
CORRESP Letter to the SEC Sep 11, 2017 —
CT ORDER Filing Aug 14, 2017 —
UPLOAD Letter from the SEC Aug 11, 2017 —
8-K/A Amended current report
Material agreement
Aug 10, 2017 May 9, 2017
CT ORDER Filing Aug 10, 2017 —
10-Q Quarterly report Aug 9, 2017 Jun 30, 2017
8-K/A Amended current report
Results of operations
Aug 9, 2017 Aug 9, 2017
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
8-K Current report
Results of operations
Aug 9, 2017 Aug 9, 2017
CT ORDER Filing Jul 11, 2017 —
8-K/A Amended current report
Material agreement, Agreement ended
Jun 2, 2017 May 15, 2017
8-K/A Amended current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 2, 2017 May 9, 2017
8-K/A Amended current report
Material agreement, Results of operations, New debt
Jun 2, 2017 May 10, 2017
8-K Current report
Material agreement, Agreement ended
May 19, 2017 May 15, 2017
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 15, 2017 May 9, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VCEL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MI
Headquarters
Burlington, MA
SEC filer status
Large accelerated filer
SEC CIK
887359
Former names
AASTROM BIOSCIENCES INC (until Nov 14, 2014)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.